Hepcinat LP (Sofosbuvir/Ledipasvir)
Sofosbuvir 400 mg / Ledipasvir 90 mg
$8.21 per tablet
Hepcinat LP Sofosbuvir/Ledipasvir
Sofosbuvir 400 mg is the drug and active component of Hepcinat LP a medication which is used in treating hepatitis C virus (HCV) infection. Hepcinat LP comes with the combination of two drugs named Sofosbuvir 400 mg and Ledipasvir 90 mg in one tablet. Sofosbuvir and Ledipasvir both of them are antiviral medications. The cure and success rate of Sofosbuvir is 30% to 97%. The drug was approved in 2012. Hepcinat LP is one of the drugs considered the safest and essential drug in the WHO essential medicines list. Checkout sofosbuvir 400 mg tablet price, Hepcinat uses, brand name, composition details.
Manufacturer of Sofosbuvir 400 mg?
Generic Sofosbuvir 400 is manufactured by Natco Pharma.
What is the brand name for Hecpinat LP?
Brand name of Hepcinat LP is Sovaldi.
History of Sofosbuvir
Sofosbuvir 400 mg is the medication which was discovered in 2007. In 2014 combination of Sofosbuvir/Ledipasvir fixed dose was used for treating Hepatitis C Virus. With a new combination for treating Hepatitis C, it increased the success rate to 97% cases of the HCV infection.
When combination of Sofosbuvir 400 mg and Ledipasvir 90 mg was launched it was found to be one the fastest acting drug for treating Hepatitis C Virus infection with success rate of 30% to 97%. Hepcinat LP belongs to one of the most important drug required for basic healthcare need.
History of Ledipasvir
Ledipasvir 90 mg is drug introduced in 2014 which is an NS5A inhibitor. NS5A is non-structural protein which influences the growth of Hepatitis C virus RNA replication. When Ledipasvir is taken orally it decreases the growth/production of HepC virus in the liver.
Some of the side effects of Hepcinat LP
- Severe rash
Hepcinat LP is also found to be effective in various types of cancer-related to the liver.
400mg + 90mg
hepatitis C virus (HCV) infection
Only logged in customers who have purchased this product may leave a review.